Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06157567 · ClinicalTrials.gov registry record · NA
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
A NA study of Wrinkle and Skin Laxity, sponsored by Candela Corporation.
- Active
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 6
- Study locations
NCT06157567 is a NA study of Wrinkle and Skin Laxity that is active but no longer recruiting, run by Candela Corporation. The registered enrollment target is 500 participants, above the 100-participant average among 25 other Wrinkle trials with a reported enrollment target (400% higher). The trial reports 6 study locations across 5 states.
The verdict
NCT06157567, a NA study of Wrinkle and Skin Laxity, is active but no longer recruiting, sponsored by Candela Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a non-randomized, multi-center, open-label clinical trial evaluating clinical feasibility treatments with the Profound Matrix system.
Conditions Studied
Interventions
- DEVICE Profound Matrix
Study Locations (6)
Other
- Waterfront Skin and Laser - Vancouver
- Candela European Institue of Excellence - Madrid
Florida
- Center for Morden Aesthetic Medicine - Jacksonville
Massachusetts
- Candela Institue for Excellence - Marlborough
North Carolina
- Concierge Medical Arts - Fayetteville
Virginia
- Gerrish MedEsthetics - Vienna
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-05-24 |
| Est. Completion | 2028-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06157567
The ClinicalTrials.gov registry entry for NCT06157567 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 100-participant average among 25 other Wrinkle trials with a reported enrollment target (400% higher). The listed sponsor is Candela Corporation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which Profound Matrix is the first listed.
NCT06157567 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Other, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06157567 about?
NCT06157567 is a clinical study titled "Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System". This is a non-randomized, multi-center, open-label clinical trial evaluating clinical feasibility treatments with the Profound Matrix system.
What is the current status of trial NCT06157567?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2022-05-24. Estimated completion is 2028-05-24.
What conditions does trial NCT06157567 study?
This clinical trial studies the following conditions: Wrinkle, Skin Laxity, Skin Condition.
What interventions are being tested in trial NCT06157567?
The interventions under investigation include: Profound Matrix (DEVICE).
Who is sponsoring clinical trial NCT06157567?
This trial is sponsored by Candela Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06157567 being conducted?
This trial has 6 study locations across Florida, Massachusetts, North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.